Treatment of respiratory infections in pregnant patients: Overview
| dc.contributor.author | Başlilar S. | |
| dc.contributor.author | Kocakaya D. | |
| dc.contributor.author | Yorgancioğlu A. | |
| dc.date.accessioned | 2025-04-10T11:04:24Z | |
| dc.date.available | 2025-04-10T11:04:24Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | It is reported that antibiotics represent almost 80% of the drugs prescribed to pregnant women and that between 1 in 5 and 1 in 4 pregnant women are administered antibiotic pharmacotherapy [1-3]. In pregnant women, the most frequently occurring infections are urinary tract infections (UTIs) (cystitis and pyelonephritis), venereal infections and the upper respiratory tract infections (URTIs) [1]. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022. | |
| dc.identifier.DOI-ID | 10.1007/978-3-031-05303-0_5 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/45353 | |
| dc.publisher | Springer International Publishing | |
| dc.title | Treatment of respiratory infections in pregnant patients: Overview | |
| dc.type | Book chapter |